TY - BOOK AU - Hayden,Cori TI - When Nature Goes Public: The Making and Unmaking of Bioprospecting in Mexico T2 - In-Formation SN - 9780691216362 AV - QK99.M498 H38 2003eb U1 - 333.95/3 PY - 2021///] CY - Princeton, NJ : PB - Princeton University Press, KW - Botanical drug industry KW - Mexico KW - Ethnoscience KW - Germplasm resources conservation KW - Indigenous peoples KW - Legal status, laws, etc KW - Intellectual property KW - Medicinal plants KW - Plant diversity conservation KW - SOCIAL SCIENCE / Anthropology / General KW - bisacsh KW - Aylward, Bruce KW - Berlin, Brent KW - Clifford, James KW - Cox, Paul KW - Delgado, Guillermo KW - Flitner, Michael KW - Fuente, Macrina KW - GATT/WTO KW - Global Exchange KW - Hersch Martínez, Paul KW - Human Genome Project KW - Janzen, Dan KW - Kohler, Robert KW - Linares, Edelmira KW - Lozoya, Xavier KW - Malthusianism KW - Monsanto KW - Morales, Gustavo KW - NIH (National Institutes of Health) KW - PROMAYA KW - Parry, Bronwyn KW - Reid, Walter KW - Strathern, Marilyn KW - Timmermann, Barbara KW - aspirin KW - biopiracy KW - ecological economics KW - economic botany KW - neem patent KW - patrimony N1 - Frontmatter --; Contents --; List of Figures and Tables --; List of Abbreviations --; Acknowledgments --; Author's Note --; Introduction --; PART ONE NEOLIBERAL NATURES --; Chapter 1 Interests and Publics: On (Ethno)science and Its Accountabilities --; Chapter 2 Neoliberalism's Nature --; Chapter 3 Prospecting in Mexico: Rights, Risk, and Regulation --; PART TWO PUBLIC PROSPECTING --; Chapter 4 Market Research: When Local Knowledge Is Public Knowledge --; Chapter 5 By the Side of the Road: The Contours of a Field Site --; PART THREE PROSPECTING'S PUBLICS --; Chapter 6 The Brine Shrimp Assay: Signs of Life, Sites of Value --; Chapter 7 Presumptions of Interest --; Chapter 8 Remaking Prospecting's Publics --; Notes --; Bibliography --; Index; restricted access N2 - Bioprospecting--the exchange of plants for corporate promises of royalties or community development assistance--has been lauded as a way to develop new medicines while offering southern nations and indigenous communities an incentive to preserve their rich biodiversity. But can pharmaceutical profits really advance conservation and indigenous rights? How much should companies pay and to whom? Who stands to gain and lose? The first anthropological study of the practices mobilized in the name and in the shadow of bioprospecting, this book takes us into the unexpected sites where Mexican scientists and American companies venture looking for medicinal plants and local knowledge. Cori Hayden tracks bioprospecting's contentious new promise--and the contradictory activities generated in its name. Focusing on a contract involving Mexico's National Autonomous University, Hayden examines the practices through which researchers, plant vendors, rural collectors, indigenous cooperatives, and other actors put prospecting to work. By paying unique attention to scientific research, she provides a key to understanding which people and plants are included in the promise of "selling biodiversity to save it"--and which are not. And she considers the consequences of linking scientific research and rural "enfranchisement" to the logics of intellectual property. Roving across UN protocols, botanical collecting histories, Mexican nationalist agendas, neoliberal property regimes, and North-South relations, When Nature Goes Public charts the myriad, emergent publics that drive and contest the global market in biodiversity and its futures UR - https://doi.org/10.1515/9780691216362?locatt=mode:legacy UR - https://www.degruyter.com/isbn/9780691216362 UR - https://www.degruyter.com/cover/covers/9780691216362.jpg ER -